Pamela V.

Pamela V. currently serves as Vice President of Health Economics and Outcomes Research (HEOR), Value & Evidence at EVERSANA, a position held since April 2024. Prior to this role, Pamela V. was with Novartis for nearly nine years, culminating as the Executive Director for Global HEOR & Access Evidence within the Oncology sector, focusing on Radioligand Therapy and real-world evidence. Pamela V. also held various positions at AbbVie, Lundbeck, and AstraZeneca, covering responsibilities in HEOR, market access, and pharmacy. Notably, Pamela V. contributed to the field as President of the ISPOR Chicago Regional Chapter and has a strong academic foundation with degrees from the University of Southern California, Harvard Medical School, and the University of Illinois Chicago.